7PDQ
Crystal structure of a mutated form of RXRalpha ligand binding domain in complex with LG100268 and a coactivator fragment
Summary for 7PDQ
Entry DOI | 10.2210/pdb7pdq/pdb |
Descriptor | Retinoic acid receptor RXR-alpha, Nuclear receptor coactivator 2, 6-[1-(3,5,5,8,8-PENTAMETHYL-5,6,7,8-TETRAHYDRONAPHTHALEN-2-YL)CYCLOPROPYL]PYRIDINE-3-CARBOXYLIC ACID, ... (4 entities in total) |
Functional Keywords | nuclear hormone receptor, nuclear protein |
Biological source | Mus musculus (Mouse) More |
Total number of polymer chains | 2 |
Total formula weight | 29218.76 |
Authors | le Maire, A.,Bourguet, W.,Guee, L. (deposition date: 2021-08-06, release date: 2022-08-03, Last modification date: 2024-01-31) |
Primary citation | le Maire, A.,Rey, M.,Vivat, V.,Guee, L.,Blanc, P.,Malosse, C.,Chamot-Rooke, J.,Germain, P.,Bourguet, W. Design and in vitro characterization of RXR variants as tools to investigate the biological role of endogenous rexinoids. J.Mol.Endocrinol., 69:377-390, 2022 Cited by PubMed: 35900852DOI: 10.1530/JME-22-0021 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.58 Å) |
Structure validation
Download full validation report